Coralville-based Viewpoint Molecular Targeting has formally merged with Isoray Inc. out of Richland, Washington to become Perspective Therapeutics. The company currently trades on the New York Stock Exchange (NYSE) as Isoray, Inc. under ticker symbol ISR which will change to…